{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:40:19Z","timestamp":1779914419115,"version":"3.53.1"},"reference-count":90,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":74,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Pierre Fabre Dermo-Cosm\u00c3\u00a9tique, France"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/bjd.13639","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T01:07:38Z","timestamp":1421456858000},"page":"27-36","source":"Crossref","is-referenced-by-count":72,"special_numbering":"supplement S1","title":["Management of severe acne"],"prefix":"10.1093","volume":"172","author":[{"given":"C.C.","family":"Zouboulis","sequence":"first","affiliation":[{"name":"Departments of Dermatology, Venereology, Allergology and Immunology; Dessau Medical Center; Auenweg 38 06847 Dessau Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bettoli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; Section of Dermatology; Azienda Ospedaliero-Universitaria di Ferrara; University of Ferrara; via Aldo Moro 8, Localit\u00e0 Cona-44100 Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"10.1111\/bjd.13639-BIB0001|bjd13639-cit-0001","first-page":"6","article-title":"Acne: current aspects on pathology and treatment","volume":"1","author":"Zouboulis","year":"1999","journal-title":"Experimental Dermatol"},{"key":"10.1111\/bjd.13639-BIB0002|bjd13639-cit-0002","first-page":"301","article-title":"Not all acne is acne vulgaris","volume":"111","author":"Gollnick","year":"2014","journal-title":"Dtsch Arztbl Int"},{"key":"10.1111\/bjd.13639-BIB0003|bjd13639-cit-0003","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2009.47","article-title":"Prevalence, severity and severity risk factors of acne in high school pupils: a community-based study","volume":"129","author":"Ghodsi","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13639-BIB0004|bjd13639-cit-0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0005|bjd13639-cit-0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjd.12912","article-title":"Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study","volume":"170","author":"Silverberg","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0006|bjd13639-cit-0006","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1038\/ncomms5020","article-title":"Genome-wide association study identifies three novel susceptibility loci for severe acne vulgaris","volume":"5","author":"Navarini","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/bjd.13639-BIB0007|bjd13639-cit-0007","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/ncomms3870","article-title":"Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne","volume":"5","author":"He","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/bjd.13639-BIB0008|bjd13639-cit-0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00439-013-1374-4","article-title":"A genome-wide association study of severe teenage acne in European Americans","volume":"133","author":"Zhang","year":"2014","journal-title":"Hum Genet"},{"key":"10.1111\/bjd.13639-BIB0009|bjd13639-cit-0009","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1742-481X.2011.00771.x","article-title":"The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring","volume":"8","author":"Chalmers","year":"2011","journal-title":"Int Wound J"},{"key":"10.1111\/bjd.13639-BIB0010|bjd13639-cit-0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archderm.1991.01680020078009","article-title":"Acne vulgaris in early adolescent boys: correlations with pubertal maturation and age","volume":"127","author":"Lucky","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13639-BIB0011|bjd13639-cit-0011","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(97)70307-X","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky","year":"1997","journal-title":"J Pediatr"},{"key":"10.1111\/bjd.13639-BIB0012|bjd13639-cit-0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clindermatol.2013.11.005","article-title":"Acne as a chronic systemic disease","volume":"32","author":"Zouboulis","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.13639-BIB0013|bjd13639-cit-0013","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1468-3083.2010.03937.x","article-title":"Acne-associated syndromes: models for better understanding of acne pathogenesis","volume":"25","author":"Chen","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13639-BIB0014|bjd13639-cit-0014","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-012-9701-4","article-title":"Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome","volume":"42","author":"Witchel","year":"2012","journal-title":"Endocrine"},{"key":"10.1111\/bjd.13639-BIB0015|bjd13639-cit-0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000067821","article-title":"Update and future of systemic acne treatment","volume":"206","author":"Zouboulis","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0016|bjd13639-cit-0016","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clindermatol.2004.03.004","article-title":"Acne and sebaceous gland function","volume":"22","author":"Zouboulis","year":"2004","journal-title":"Clin Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13639-BIB0017|bjd13639-cit-0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13639-BIB0018|bjd13639-cit-0018","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0190-9622(93)70076-6","article-title":"Acne fulminans. Report of clinical findings and treatment of twenty-four patients","volume":"28","author":"Karvonen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0019|bjd13639-cit-0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2133.1999.02982.x","article-title":"The treatment of acne fulminans: A review of 25 cases","volume":"141","author":"Seukeran","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0020|bjd13639-cit-0020","first-page":"473","article-title":"Treatment of acne fulminans with isotretinoin and prednisolone","volume":"76","author":"Bass","year":"2001","journal-title":"Z Hautkr"},{"key":"10.1111\/bjd.13639-BIB0021|bjd13639-cit-0021","first-page":"208","article-title":"Efficacy of tetracyclines in the treatment of acne vulgaris: a review","volume":"158","author":"Simonart","year":"2008","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13639-BIB0022|bjd13639-cit-0022","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1111\/j.1610-0387.2006.06053_suppx.x","article-title":"[Systemic antibiotic therapy of acne vulgaris","volume":"8","author":"Ochsendorf","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13639-BIB0023|bjd13639-cit-0023","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"key":"10.1111\/bjd.13639-BIB0024|bjd13639-cit-0024","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2230.1993.tb02242.x","article-title":"Phototoxic eruptions due to doxycycline - a dose-related phenomenon","volume":"18","author":"Layton","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.13639-BIB0025|bjd13639-cit-0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2133.2003.05389.x","article-title":"High-level ultraviolet A photoprotection is needed to prevent doxycycline phototoxicity: lessons learned in East Timor","volume":"149","author":"Lim","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0026|bjd13639-cit-0026","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/11319280-000000000-00000","article-title":"Minocycline in acne vulgaris: benefits and risks","volume":"11","author":"Ochsendorf","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.13639-BIB0027|bjd13639-cit-0027","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2133.1994.tb02933.x","article-title":"Differences in phototoxic potency should be considered when tetracyclines are prescribed during summer-time. A study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema","volume":"130","author":"Bjellerup","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0028|bjd13639-cit-0028","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.1987.tb05853.x","article-title":"Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris","volume":"116","author":"Katsambas","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0029|bjd13639-cit-0029","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: a myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13639-BIB0030|bjd13639-cit-0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000354888","article-title":"Azelaic acid: properties and mode of action","volume":"27","author":"Sieber","year":"2014","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1111\/bjd.13639-BIB0031|bjd13639-cit-0031","first-page":"538","article-title":"Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne","volume":"11","author":"Gollnick","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0032|bjd13639-cit-0032","first-page":"157","article-title":"[The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type]","volume":"60","author":"Gollnick","year":"1999","journal-title":"Ann Endocrinol (Paris)"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13639-BIB0033|bjd13639-cit-0033","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","article-title":"[Hormonal antiandrogens in acne therapy]","volume":"8","author":"Zouboulis","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.13639-BIB0034|bjd13639-cit-0034","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2001.01312.x","article-title":"Sebocytes are the key regulators of androgen homeostasis in human skin","volume":"116","author":"Fritsch","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13639-BIB0035|bjd13639-cit-0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2007-961814","article-title":"Inhibition of 5\u03b1-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro","volume":"39","author":"Seiffert","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1111\/bjd.13639-BIB0036|bjd13639-cit-0036","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/bjd.13639-BIB0037|bjd13639-cit-0037","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0038|bjd13639-cit-0038","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000017848","article-title":"Oral retinoids in the treatment of seborrhoea and acne","volume":"196","author":"Orfanos","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0039|bjd13639-cit-0039","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2133.1993.tb11849.x","article-title":"Isotretinoin for acne vulgaris -10\u00a0years later: a safe and successful treatment","volume":"129","author":"Layton","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0040|bjd13639-cit-0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/17469872.2.6.693","article-title":"Isotretinoin: state of the art treatment for acne vulgaris","volume":"2","author":"Ganceviciene","year":"2007","journal-title":"Expert Rev Dermatol"},{"key":"10.1111\/bjd.13639-BIB0041|bjd13639-cit-0041","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1523-1747.ep12285658","article-title":"Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata","volume":"86","author":"Leyden","year":"1986","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13639-BIB0042|bjd13639-cit-0042","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(82)70063-5","article-title":"Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study","volume":"6","author":"Peck","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0043|bjd13639-cit-0043","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mjd.2001.115965","article-title":"A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne","volume":"45","author":"Strauss","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0044|bjd13639-cit-0044","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a multicenter dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0045|bjd13639-cit-0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1983.tb03973.x","article-title":"A dose-response study of 13-cis-retinoic acid in acne vulgaris","volume":"108","author":"Jones","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0046|bjd13639-cit-0046","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1982.tb00410.x","article-title":"A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population","volume":"107","author":"King","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0047|bjd13639-cit-0047","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000249803","article-title":"Dose-response relationship in isotretinoin therapy for conglobate acne","volume":"167","author":"Meeren","year":"1983","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.13639-BIB0048|bjd13639-cit-0048","first-page":"1","article-title":"A study of isotretinoin (Roaccutan) in nodulocystic acne","volume":"23","author":"Al Mishari","year":"1986","journal-title":"Clin Trials J"},{"key":"10.1111\/bjd.13639-BIB0049|bjd13639-cit-0049","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000249321","article-title":"Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism","volume":"172","author":"Pigatto","year":"1986","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.13639-BIB0050|bjd13639-cit-0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1985.tb05458.x","article-title":"Isotretinoin and tetracycline in the management of severe nodulocystic acne","volume":"24","author":"Lester","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0051|bjd13639-cit-0051","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/bjd.13191","article-title":"A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin","volume":"171","author":"Tan","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0052|bjd13639-cit-0052","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0378-6323.39727","article-title":"Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne","volume":"74","author":"Dhir","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.13639-BIB0053|bjd13639-cit-0053","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2133.1993.tb11850.x","article-title":"Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?","volume":"129","author":"Stainforth","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0054|bjd13639-cit-0054","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000248038","article-title":"Isotretinoin and acne: a study of relapses","volume":"180","author":"Chivot","year":"1990","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.13639-BIB0055|bjd13639-cit-0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000090646","article-title":"The truth behind this undeniable efficacy - recurrence rates and relapse risk factors of acne treatment with oral isotretinoin","volume":"212","author":"Zouboulis","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0056|bjd13639-cit-0056","volume-title":"European Directive for Systemic Isotretinoin Prescription","author":"European Medicines Agency - Committee for Proprietary Medicinal Products","year":"2003"},{"key":"10.1111\/bjd.13639-BIB0057|bjd13639-cit-0057","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","article-title":"A review of the European directive for prescribing systemic isotretinoin for acne vulgaris","volume":"20","author":"Layton","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13639-BIB0058|bjd13639-cit-0058","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2011.04.006","article-title":"Isotretinoin and iPledge: a view of results","volume":"65","author":"Maloney","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0059|bjd13639-cit-0059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40257-013-0014-z","article-title":"Important controversies associated with isotretinoin therapy for acne","volume":"14","author":"Wolverton","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.13639-BIB0060|bjd13639-cit-0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/bjd.13639-BIB0061|bjd13639-cit-0061","doi-asserted-by":"crossref","first-page":"c5812","DOI":"10.1136\/bmj.c5812","article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study","volume":"341","author":"Sundstr\u00f6m","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/bjd.13639-BIB0062|bjd13639-cit-0062","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/jid.2012.387","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study","volume":"133","author":"Alhusayen","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13639-BIB0063|bjd13639-cit-0063","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.13639-BIB0064|bjd13639-cit-0064","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2014.8","article-title":"Isotretinoin and risk of inflammatory bowel disease: a French nationwide study","volume":"109","author":"Racine","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.13639-BIB0065|bjd13639-cit-0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9394(01)01024-8","article-title":"Ocular side effects possibly associated with isotretinoin usage","volume":"132","author":"Fraunfelder","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/bjd.13639-BIB0066|bjd13639-cit-0066","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00414-012-0750-2","article-title":"Severe generalised rhabdomyolysis with fatal outcome associated with isotretinoin","volume":"126","author":"Hartung","year":"2012","journal-title":"Int J Legal Med"},{"key":"10.1111\/bjd.13639-BIB0067|bjd13639-cit-0067","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1185\/030079906X96326","article-title":"Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane","volume":"22","author":"Taylor","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/bjd.13639-BIB0068|bjd13639-cit-0068","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/pds.3565","article-title":"Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies","volume":"23","author":"Lagan","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/bjd.13639-BIB0069|bjd13639-cit-0069","first-page":"41","article-title":"Low-dose schema of isotretinoin in acne vulgaris","volume":"23","author":"Mandekou-Lefaki","year":"2003","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1111\/bjd.13639-BIB0070|bjd13639-cit-0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1468-3083.2010.03933.x","article-title":"Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission","volume":"25","author":"Borghi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13639-BIB0071|bjd13639-cit-0071","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2013.05.036","article-title":"Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study","volume":"69","author":"Webster","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13639-BIB0072|bjd13639-cit-0072","first-page":"665","article-title":"Results of a phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-lidose in patients with severe recalcitrant nodular acne","volume":"13","author":"Webster","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13639-BIB0073|bjd13639-cit-0073","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","article-title":"Antibiotic stewardship in dermatology: limiting antibiotic use in acne","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0074|bjd13639-cit-0074","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000051771","article-title":"Is acne vulgaris a genuine inflammatory disease?","volume":"203","author":"Zouboulis","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0075|bjd13639-cit-0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.0906-6705.2005.0285a.x","article-title":"What is the pathogenesis of acne?","volume":"14","author":"Zouboulis","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.13639-BIB0076|bjd13639-cit-0076","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00109-005-0715-8","article-title":"Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands","volume":"84","author":"Alestas","year":"2006","journal-title":"J Mol Med"},{"key":"10.1111\/bjd.13639-BIB0077|bjd13639-cit-0077","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archderm.139.5.668","article-title":"A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor","volume":"139","author":"Zouboulis","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13639-BIB0078|bjd13639-cit-0078","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/derm.1.3.8368","article-title":"Zileuton, a new efficient and safe systemic anti-acne drug","volume":"1","author":"Zouboulis","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1111\/bjd.13639-BIB0079|bjd13639-cit-0079","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081481","article-title":"Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production","volume":"210","author":"Zouboulis","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0080|bjd13639-cit-0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0625.2009.00929.x","article-title":"Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis","volume":"19","author":"Zouboulis","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.13639-BIB0081|bjd13639-cit-0081","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000053272","article-title":"Neuroimmunoregulation of androgens in the adrenal gland and the skin","volume":"54","author":"Alesci","year":"2000","journal-title":"Horm Res"},{"key":"10.1111\/bjd.13639-BIB0082|bjd13639-cit-0082","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archderm.1982.01650200023009","article-title":"Isotretinoin in the treatment of acne: histologic changes, sebum production, and clinical observations","volume":"118","author":"Goldstein","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13639-BIB0083|bjd13639-cit-0083","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00414230","article-title":"13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers","volume":"276","author":"Hennes","year":"1984","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.13639-BIB0084|bjd13639-cit-0084","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000249320","article-title":"The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study","volume":"172","author":"Harms","year":"1986","journal-title":"Dermatologica"},{"issue":"Suppl. 1","key":"10.1111\/bjd.13639-BIB0085|bjd13639-cit-0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000248869","article-title":"Isotretinoin - an explanation for its long-term benefit","volume":"175","author":"Cunliffe","year":"1987","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.13639-BIB0086|bjd13639-cit-0086","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000247322","article-title":"Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9\u00a0years","volume":"186","author":"Lehucher-Ceyrac","year":"1993","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0087|bjd13639-cit-0087","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000018130","article-title":"Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients","volume":"198","author":"Lehucher-Ceyrac","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13639-BIB0088|bjd13639-cit-0088","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-4362.1994.tb01500.x","article-title":"Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore","volume":"33","author":"Shahidullah","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0089|bjd13639-cit-0089","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1997.tb03710.x","article-title":"Treatment of acne with intermittent isotretinoin","volume":"137","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13639-BIB0090|bjd13639-cit-0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/2277-9175.129693","article-title":"Efficacy of fixed daily 20\u00a0mg of isotretinoin in moderate to severe scar prone acne","volume":"3","author":"Rasi","year":"2014","journal-title":"Adv Biomed Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13639\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:13:31Z","timestamp":1676366011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/S1\/27\/6615742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":90,"URL":"https:\/\/doi.org\/10.1111\/bjd.13639","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,19]]}}}